Evidence map›Paper›PMID 40157941›Full record

ArticleScientific reports2025

A group based network analysis for Alzheimer's disease fMRI data.

Yikun Zhou, Shuang Gao, Lingli Deng, Genjin Lin, Jiyang Dong

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yikun ZhouInstitute of Artificial Intelligence, Xiamen University, Xiamen, 361005, China.
Shuang GaoDepartment of Electronic Science, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361005, China.
Lingli DengDepartment of Information Engineering, East China University of Technology, Nanchang, 330013, China. denglingli1987@sina.com.
Genjin LinDepartment of Electronic Science, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361005, China.
Jiyang DongDepartment of Electronic Science, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361005, China. jydong@xmu.edu.cn.

Funding

National Natural Science Foundation of China 82360363National Natural Science Foundation of China 82372087Natural Science Foundation of Fujian Province 2022Y0003Natural Science Foundation of Jiangxi Province 20232BAB206136
6 · The paper itself

Abstract

Network modeling are widely using in resting-state functional magnetic resonance imaging (rs-fMRI) for Alzheimer's disease (AD) research. Typically, Pearson correlation coefficient (PCC) was widely applied to construct brain connectivity network from BOLD signals of regions of interest. However, it often results in significant intra-group variability and complicates the identification of disease-specific functional connectivity patterns. To address this issue, we propose a novel brain network construction strategy, called SNBG, which uses aggregated information from the control group to derive a single-sample network. We compare SNBG and the PCC based method on a dataset from an Alzheimer's Disease Neuroimaging Initiative (ADNI) study. SNBG method captures more stable connections between regions of interest (ROIs) and increases classification accuracy from 89.24% of PCC based method to 97.13%. In addition, in AD-related local networks, such as default mode network (DMN), medial frontal network (MFN) and frontoparietal network (FPN), SNBG demonstrates lower intra-group heterogeneity than the PCC based method.

Indexed as

Alzheimer DiseaseBrainMagnetic Resonance ImagingNerve NetAgedBrain MappingFemaleHumansMale

Identifiers

PMID40157941
PMCPMC11954933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.